Anti Parkinson Drugs

Unique minitablets in a dispenser that counts the minitablets, to allow for flexible and fine-tuned dosing of Levodopa for Parkinson's Disease patients. Launched in the Nordics. (Not approved in Italy)

API manufacturer with biocatalysis using Category I GMO. Biotransformation platforms. CRO/CDMO activities.

Levodopa / Carbidopa / Entacapone is a fixed-dose antiparkinson combination used in the treatment of Parkinson’s disease. Levodopa acts as a dopamine precursor, carbidopa inhibits its peripheral conversion, and entacapone prolongs the therapeutic effect of levodopa by inhibiting COMT-mediated metabolism. T...

Our products include: 

• Atosiban • Bortezomib • Cabazitaxel • Carbetocin • Cerebrolysin • Dacepton (Apomorphine) • Decitabine • Dexemedetomidine • Docetaxel • Eribulin • Fulvestrant • Oxytocin • Paclitaxel • Pemetrexed • Terlipressin • Testosterone Enantate • Testosterone ...

The APOSAN® Pen is a portable, multi‑dose injection device launched in India by Rusan Healthcare for Parkinson’s patients. It delivers apomorphine hydrochloride (10 mg/ml) via 3 ml pre‑filled cartridges, designed to provide rapid relief from “ON‑OFF” motor fluctuations.

Piribedil, a dopamine receptor agonist, is used to treat Parkinson's disease, aiding in improving motor symptoms such as tremors, rigidity, and bradykinesia.

Designed for the delivery of high-volume, high-viscosity biologics, EZ-fill® Large Volume Cartridges support treatments for several conditions such as autoimmune, oncology, rare diseases and Parkinson’s. 
With 10+ years of expertise in large-volume containers, we are a trusted partner for...

EIPICO offers a wide range of cholinergic muscle stimulants which includes epistigmin ®, neostigmine methylsulphate. It belongs to musculoskeltal system drugs category. Contact us for more information.

Methanesulfonate salt of safinamide, a selective and reversible monoamine oxidase-B (MAO-B) inhibitor used as an adjunct treatment for Parkinson's disease.
Crystalline anhydrous form A1

Documentation: DMF EU, DMF US

Therapeutic Use : Treatment of hyperprolactinemia and Parkinson’s disease

For the treatment of Parkinson's disease and Parkinson's syndrome

tablets 100/25 mg, 200/50 mgcapsules 50/12.5 mg, 100/25 mg, 200/50 mg
dispersible tablets 50/12.5 mg, 100/25 mg, 200/50 mg

Anti-Parkinson

Package:25kg/drum

End Application: Flupirtine, Raltegravir, Pimavanserin 

Therapeutic Area: Nervous System Therapeutic Class: Anti-Parkinson Preparations 
Application Areas: Treatment of idiopathic Parkinson’s disease as monotherapy or as adjunctive therapy to levodopa in patients with motor fluctuations, subject to the approved local prescribing information.

Levodopa / Carbidopa is an antiparkinson combination used for the symptomatic treatment of Parkinson’s disease and parkinsonian syndromes. Levodopa acts as a dopamine precursor, while carbidopa reduces the peripheral conversion of levodopa, helping increase its availability to the central nervous system. T...

Apomorphine Hydrochloride Injection 10mg/ml

EU DMF, NMPA CDE, JDMF, EHO-GMP, Written Confirmation 

Under validation